The total return over the past 12 months is -45.36% vs. +16.94% for the S&P 500. So far it's up -51.29% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (45.36%) | (46.10%) | N/A | N/A | N/A | N/A |
| Total Return CAGR | (45.36%) | (46.10%) | N/A | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
MIRA Pharmaceuticals, Inc. (MIRA)
| Year | Start price | End price | MIRA Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.51 | $0.74 | (51.29%) | +14.51% | (65.80%) |
| 2025 | $1.14 | $1.51 | +32.46% | +17.72% | +14.74% |
| 2024 | $1.05 | $1.14 | +8.57% | +24.89% | (16.32%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
